Valuation: Kim Forest Enterprise Co., Ltd.

Market Cap 755M 23.74M 20.83M 19.56M 17.91M 33.44M 2.27B 33.77M 235M 91.07M 1.16B 89.15M 87.2M 3.76B P/E 2024
-7.91x
P/E 2025 -7.34x
Enterprise Value 1.01B 31.92M 28.01M 26.3M 24.08M 44.96M 3.06B 45.4M 316M 122M 1.56B 120M 117M 5.05B EV / Sales 2024
2.86x
EV / Sales 2025 2.43x
Free-Float
43.95%
Yield 2024 *
-
Yield 2025 -
1 day-0.79%
1 week-1.19%
Current month+1.63%
1 month-4.21%
3 months-25.15%
6 months-10.39%
Current year-29.38%
1 week 12.15
Extreme 12.15
12.8
1 month 12.15
Extreme 12.15
13.6
Current year 11.4
Extreme 11.4
18.5
1 year 11.4
Extreme 11.4
26.45
3 years 11.4
Extreme 11.4
48.1
5 years 11.4
Extreme 11.4
50.38
10 years 8.27
Extreme 8.27329
122.57
Manager TitleAgeSince
Chief Executive Officer - 01/07/2005
Director of Finance/CFO - 02/12/2013
Chief Tech/Sci/R&D Officer - 01/11/2016
Director TitleAgeSince
Chairman - 22/09/2014
Director/Board Member - 28/07/2004
Director/Board Member - 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-1.19%-47.92%-70.96% 24.02M
-6.95%-13.69% - - 1.27B
-3.25%+1.06%-33.66%-37.07% 719M
+0.18%-6.02%+57.25% - 359M
+0.59%+7.38%-40.89%-23.60% 127M
+0.54%+5.65%-15.38%+17.61% 72.1M
Average -1.61%+0.69%-16.12%-28.51% 429.28M
Weighted average by Cap. -4.28%-4.78%-8.54%-31.93%

Financials

2024 2025
Net sales 502M 15.77M 13.84M 12.99M 11.9M 22.22M 1.51B 22.44M 156M 60.51M 771M 59.23M 57.94M 2.5B 549M 17.27M 15.15M 14.23M 13.03M 24.33M 1.65B 24.57M 171M 66.26M 844M 64.86M 63.44M 2.73B
Net income -160M -5.03M -4.41M -4.14M -3.79M -7.08M -481M -7.15M -49.82M -19.29M -246M -18.88M -18.47M -796M -146M -4.61M -4.04M -3.79M -3.47M -6.49M -441M -6.55M -45.64M -17.67M -225M -17.3M -16.92M -729M
Net Debt 147M 4.61M 4.04M 3.8M 3.48M 6.49M 441M 6.55M 45.65M 17.68M 225M 17.3M 16.92M 729M 260M 8.18M 7.18M 6.74M 6.17M 11.52M 783M 11.64M 81.06M 31.38M 400M 30.72M 30.05M 1.3B
Logo Kim Forest Enterprise Co., Ltd.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Employees
-
Date Price Change Volume
23/09/26 NT$12.50 -0.79% 2,773
22/09/26 NT$12.60 +1.20% 44,605
21/09/26 NT$12.45 -1.19% 41,900
18/09/26 NT$12.60 +0.80% 47,359
17/09/26 NT$12.50 -1.19% 38,382
  1. Stock Market
  2. Stocks
  3. 6645 Stock